The Calm We Remember
De-Stress Peptides™

Biotics Research Clinical Education Team

There’s a reason warm milk has been a bedtime ritual for centuries. But it wasn’t until the 1990s that researchers at the University of Nancy in France discovered why it works. They observed that newborns become remarkably calm after drinking milk, whether through breast milk or other milk sources—not simply because they’re full, but because of something specific happening during digestion. The enzyme trypsin, naturally abundant in an infant’s gut, breaks down a milk protein called alpha(s1)-casein and releases a ten-amino-acid peptide with an unusual property: it binds to GABA-A receptors in the brain in much the same way benzodiazepines do—without the sedation, dependency, or side effects.

That peptide is alpha-casozepine. In 2001, Miclo and colleagues published the first characterization of alpha-casozepine in the FASEB Journal, confirming its benzodiazepine-like activity through selective GABA receptor modulation.¹ What began as a curiosity about infant behavior had become a credentialed bioactive compound.

The clinical evidence that followed has been substantial. In a randomized, placebo-controlled hemodynamic trial of 42 healthy men, Messaoudi et al. demonstrated that a single 200 mg dose of alpha-casozepine reduced plasma cortisol by 20.7% (P=0.001) during acute psychological stress—compared to just 3.39% in the placebo group. The same subjects showed significantly lower systolic and diastolic blood pressure and reduced heart rate under stress.² These aren’t subjective reports; they’re measurable, hemodynamic outcomes. measurable, hemodynamic outcomes.

A broader picture of stress resilience emerged from the PROCLAIM trial, a double-blind crossover study involving 63 women who took 150 mg daily for 30 days. Kim et al. reported statistically significant improvements across digestive, cardiovascular, intellectual, emotional, and social symptom domains—with digestive symptoms improving by over 66% and intellectual symptoms by nearly 65%.³ The crossover design, where each participant served as her own control, strengthened the findings considerably.

More recently, a 2019 randomized, double-blind, placebo-controlled trial by de Saint-Hilaire and colleagues confirmed the sleep benefits of 150 mg/day over four weeks. Participants fell asleep faster, slept longer, and showed improved sleep efficiency—all confirmed by polysomnography and actigraphy, the gold standards for objective sleep measurement.⁴

Alpha-casozepine became the foundation of Lactium®, the clinically validated ingredient behind De-Stress Peptides™ from Biotics Research. What makes this product remarkable isn't any single finding—it's the convergence. A compound born from observing the simplest human interaction, a mother feeding her child, now has over two decades of peer-reviewed research behind it. It modulates stress through a mechanism the body already recognizes, supports cortisol balance without suppression, and promotes restorative sleep without sedation.

References

1. Miclo L, Perrin E, Driou A, et al. Characterization of alpha-casozepine, a tryptic peptide from bovine alpha(s1)-casein with benzodiazepine-like activity. FASEB J. 2001;15(10):1780–1782.
2. Messaoudi M, Lefranc-Millot C, Desor D, Demagny B, Bourdon L. Effects of a tryptic hydrolysate from bovine milk alpha(s1)-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. Eur J Nutr. 2005;44(2):128–132.
3. Kim JH, Desor D, Kim YT, et al. Efficacy of alpha(s1)-casein hydrolysate on stress-related symptoms in women. Eur J Clin Nutr. 2007;61(4):536–541.
4. de Saint-Hilaire Z, Messaoudi M, Desor D, Kobayashi T. Effects of a bovine alpha(s1)-casein hydrolysate on sleep disturbance. Nutrients. 2019.